Organic Letters p. 6450 - 6454 (2021)
Update date:2022-08-11
Topics:
Du, Luan
Li, Baosheng
Li, Shanshan
Li, Yingzi
Li, You
Luo, Han
Tang, Zongyuan
Xin, Xiaolan
A new catalytic protocol to access synthetically challenging cis-2,3-dihydroazepines is reported. The reaction starts with readily available dienals, alkynes, and sulfonyl azides as the substrates and employs copper and rhodium as relay catalysts. Key steps include a copper-catalyzed reaction between an alkyne and a sulfonyl azide to form a triazole intermediate. The subsequent activation of this triazole intermediate by a rhodium catalyst, followed by a reaction with the dienal substrate, eventually leads to the dihydroazepine product. The regio- and stereochemistries of the products are believed to be controlled through a stereospecific conrotatory 8π-electrocyclization process against a possible competing 6π-electrocyclization process.
View MoreBeijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Luzhou North Chemical Co., Ltd.
Contact:+86-830-2796784;+86-830-2796776
Address:Gaoba, Longmatan District, Luzhou, Sichuan Province
Jiangsu Taihu New Materials Holding Co., Ltd
Contact:+86-519-86160108
Address:Xueyan Town, Changzhou City, Jiangsu Province, 213169, China
Wuxi D-Stone International Co., Ltd.
Contact:+86-510-82740567
Address:21F Hengtong Int'l Centre, 215Zhongshan Road, Wuxi, Jiangsu,China
HUNAN CHEMAPI BIOLOGICAL TECHNOLOGY CO.,LTD.
Contact:+86-186-02659358
Address:1004, building 3, Wanke Jinsemaitianyuan, 498 Guitang Road, Yuhua District, Changsha City, Hunan Province, China
Doi:10.1016/j.bmc.2015.08.035
(2015)Doi:10.1016/0022-328X(95)05661-8
(1996)Doi:10.1016/j.cclet.2010.01.027
(2010)Doi:10.1002/chem.201705713
(2018)Doi:10.1016/0022-328X(88)83077-8
(1988)Doi:10.1063/1.1731174
(1960)